Yahoo

Clorox (CLX) Stock Looks About Right Based On Earnings Today

Trade Clorox on Coinbase

Clorox trades around US$88.67 after a difficult few years for shareholders, which raises a simple question for you as an investor. Is the current share price properly supported by the earnings power of this consumer staples business?

  • Over the past 5 years, the stock has fallen 35.3%, so the key issue is whether the current earnings base now justifies a reset valuation.

  • Recent discussion around a high dividend payout and inflation pressure on costs puts the focus firmly on margins and how much profit Clorox can realistically retain for shareholders.

  • Your read on Clorox is one view; the desks covering it have another. See what analysts think Clorox's shares could be worth .

The stock's next move may depend on whether Clorox's present earnings are enough to support today's price or if expectations built into that valuation need to adjust.

If you want to stress test this same earnings question beyond Clorox, compare it against solid balance sheet and fundamentals stocks screener (22 results) .

Is Clorox Fairly Priced on Earnings?

The P/E ratio is a straightforward way to gauge what you are paying today for each dollar of Clorox earnings. Clorox currently trades on a P/E of about 18.3x, which sits between the Household Products industry average of roughly 16.7x and the peer group level around 21.7x.

On this metric, the stock lines up close to the multiple implied by a more tailored fair-value framework that blends its sector, margins, growth assumptions and risk profile. As a result, the market price does not screen as either aggressively cheap or extremely expensive on earnings alone. Because recent commentary has focused on dividend pressure and cost inflation, this middle-of-the-pack P/E suggests investors are already weighing those issues rather than pricing in either a sharp recovery or a major setback. To judge whether that is acceptable for your own portfolio, you would need to decide how durable Clorox earnings look against those margin and cash flow questions. Explore the numbers behind Clorox's P/E valuation .

NYSE:CLX P/E Ratio as at Oct 2026
NYSE:CLX P/E Ratio as at Oct 2026

The Clorox Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where that valuation question for Clorox leaves off. They spell out which future paths for earnings, margins and growth would need to occur for the stock to appear meaningfully under or over-valued at today's level. Each scenario treats fair value as a thesis about how Clorox's business might evolve that you can revisit over time, rather than as a one-off snapshot.

Community views on Clorox are split between those who see health and hygiene as a reset for the business and those who focus on cash flow and execution risk.

Bull case: 9% undervalued

"Expansion of health and hygiene as Clorox's main focus, including the GOJO and Clorox Healthcare platforms that now represent over half of company sales…"

Discover why this Narrative puts Clorox at 9% undervalued .

Bear case: 20% overvalued

"The numbers on revenue trends, free cash flow margin compression, elevated dividend payout and guided earnings growth imply a share price that already reflects a smooth execution…"

Explore why this Narrative puts Clorox at 20% overvalued .

Before you act on Clorox's valuation, there is one more angle to check

Clorox's share price and P/E only tell part of the story, because internal risk checks have highlighted specific concerns that some investors may want to review closely before getting comfortable. Take a closer look at 2 warning signs (2 major) before settling on a valuation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CLX .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: